MICHAEL E. PREVOZNIK - 14 Feb 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Signature
Sean D. Mersten, Attorney in Fact for Michael E. Prevoznik
Issuer symbol
DGX
Transactions as of
14 Feb 2024
Transactions value $
$0
Form type
4
Filing time
16 Feb 2024, 20:04:15 UTC
Previous filing
19 Jan 2024
Next filing
23 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DGX Common Stock Award $0 +2.94K +7.66% $0.00 41.3K 14 Feb 2024 Direct F1
holding DGX Common Stock 5.54K 14 Feb 2024 401(k)/SDCP F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DGX Non-Qualifed Stock Option (right to buy) Award $0 +12.2K $0.00 12.2K 14 Feb 2024 Common Stock 12.2K $127.81 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted share units.
F2 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
F3 The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.